Saußele, S., Müller, M. C., Fabarius, A., & Hofmann, W. (2018). Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): A prespecified interim analysis of a prospective, multicentre, non-randomised, trial. The lancet. Oncology, 19(6), . https://doi.org/10.1016/S1470-2045(18)30192-X
Chicago-Zitierstil (17. Ausg.)Saußele, Susanne, Martin Christian Müller, Alice Fabarius, und Wolf-Karsten Hofmann. "Discontinuation of Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia (EURO-SKI): A Prespecified Interim Analysis of a Prospective, Multicentre, Non-randomised, Trial." The Lancet. Oncology 19, no. 6 (2018). https://doi.org/10.1016/S1470-2045(18)30192-X.
MLA-Zitierstil (9. Ausg.)Saußele, Susanne, et al. "Discontinuation of Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia (EURO-SKI): A Prespecified Interim Analysis of a Prospective, Multicentre, Non-randomised, Trial." The Lancet. Oncology, vol. 19, no. 6, 2018, https://doi.org/10.1016/S1470-2045(18)30192-X.